Anti-Human TLR4 Monoclonal Antibody (1A057) (HT205025)

Name: Anti-Human TLR4 Monoclonal Antibody (1A057)
Brand: abinScience
SKU: HT205025
Price: 106 USD
Availability: InStock

Datasheet Share product Copy info

Price(USD):

Spec:

20ug
50ug
100ug

Number:

Get quote

Overview
Images
References
Datasheet
SDS

Overview

Catalog No.	HT205025
Description	Anti-Human CD284/TLR4 Monoclonal Antibody (1A057) [1A057] (HT205025) is a mouse monoclonal antibody detecting CD284 in ELISA, IHC, WB. Suitable for Human. Highlights ●Recombinant — Superior batch-to-batch reproducibility with defined sequences. ●Multi-Application — Validated across multiple applications.
Species reactivity	Human
Applications	ELISA, IHC, WB
Host species	Mouse
Clonality	Monoclonal
Isotype	IgG3
Clone ID	1A057
Immunogen	Mammalian cells - derived recombinant Human CD284 / TLR4 (Met1-Lys631).
Target	Toll-like receptor 4, TLR4, CD284, hToll,
Endotoxin level	< 10 EU/mg
Purity	>95% as determined by SDS-PAGE.
Purification	Protein A/G purified from cell culture supernatant.
Form	Liquid
Storage buffer	0.01M PBS pH 7.4. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
Stability and Storage	Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background	Toll-like receptor 4 (CD284/TLR4) is a ~95 kDa protein. Transmembrane receptor that functions as a pattern recognition receptor recognizing pathogen- and damage-associated molecular patterns (PAMPs and DAMPs) to induce innate immune responses via downstream signaling pathways. At the plasma membrane, cooperates with LY96 to mediate the innate immune response to bacterial lipopolysaccharide (LPS). Also involved in LPS-independent inflammatory responses triggered by free fatty acids, such as palmitate, and Ni(2+). Mechanistically, acts via MYD88, TIRAP and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Alternatively, CD14-mediated TLR4 internalization via endocytosis is associated with the initiation of a MYD88-independent signaling via the TICAM1-TBK1-IRF3 axis leading to type I interferon production. 1. Arbour, NC. et al. (2000) Nature genetics 25, 187-91. PMID: 10835634 2. Bulut, Y. et al. (2005) The Journal of biological chemistry 280, 20961-7. PMID: 15809303 3. Jung, SB. et al. (2006) Infection and immunity 74, 2686-96. PMID: 16622205 4. Georgel, P. et al. (2007) Virology 362, 304-13. PMID: 17292937 5. Kim, F. et al. (2007) Circulation research 100, 1589-96. PMID: 17478729 6. Stewart, CR. et al. (2010) Nature immunology 11, 155-61. PMID: 20037584 7. Schmidt, M. et al. (2010) Nature immunology 11, 814-9. PMID: 20711192 8. Estruch, M. et al. (2013) Atherosclerosis 229, 356-62. PMID: 23880187 9. Tatematsu, M. et al. (2016) Journal of immunology (Baltimore, Md. : 1950) 196, 3865-76. PMID: 27022195 10. Xiahou, Z. et al. (2017) Nature communications 8, 950. PMID: 29038465
Note	For research use only.